Alterity Therapeutics-ADRATHE
13F holders, Q1 2025 (March 31)12holders −1
2new positions
2sold out
1famous investor
$3.45avg. 13F price*
At the end of Q1 2025, 12 institutions reported holding Alterity Therapeutics-ADR (ATHE) in their 13F filings, down 1 from Q4 2024. 2 opened new positions and 2 sold out. The largest holders were Point72 Asset Management ($453K), Morgan Stanley ($151K) and HB Wealth Management, LLC ($129K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Alterity Therapeutics-ADR
- CUSIP
- 02155X205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $634 |
| Exits | 2 | $71 |
All 13F filers, Q4 2024 → Q1 2025: 118,169 shares bought and 721 shares sold, net +117,448 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Point72 Asset Management | 0.00% | Add +302.8% | 131,431 | $453K |
| Morgan Stanley | 0.00% | Reduce -1.6% | 43,701 | $151K |
| HB Wealth Management, LLC | 0.00% | Add +17.6% | 37,483 | $129K |
| UBS Group AG | 0.00% | Add +3286.5% | 13,004 | $45K |
| BNP Paribas Financial Markets | 0.00% | Add +10.9% | 9,752 | $34K |
| Twin Lakes Capital Management, LLC | 0.01% | No change | 5,925 | $20K |
| Osaic Holdings, Inc. | 0.00% | No change | 181 | $626 |
| Rhumbline Advisers | 0.00% | New | 130 | $450 |
| JPMorgan Chase & Co. | 0.00% | New | 53 | $184 |
| Blue Trust, Inc. | 0.00% | No change | 40 | $138 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $21 |
| Danske Bank A/S | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is ATHE's weight in each manager's 13F, not the share of Alterity Therapeutics-ADR the manager owns.